Literature DB >> 1527429

Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS-associated Staphylococcus aureus isolates.

V T Lee1, A H Chang, A W Chow.   

Abstract

The association between staphylococcal enterotoxin (SE) B and toxic shock syndrome (TSS) toxin 1 (TSST-1) in menstrual and nonmenstrual TSS was examined. Production of SEB and TSST-1 in the culture supernatants from 344 Staphylococcus aureus isolates was quantitated by noncompetitive ELISA (lower detection limit, 0.5 ng/mL for both assays). In the ELISA for SEB, cross-reactive antibodies to SEC were removed by absorption in a biotin-streptavidin-agarose column (SEC1 at concentrations to 100,000 ng/mL could not be detected). Among TSST-1-negative isolates, SEB production in nonmenstrual TSS isolates (8/13, 62%) was more prevalent than that in either menstrual TSS isolates (1/4; P = .3), non-TSS infections (15/103, 15%; P less than .001), or asymptomatic carriers (14/105, 13%; P less than .001). Expression of SEB and TSST-1 was usually mutually exclusive (only 1.5% of 344 isolates produced both SEB and TSST-1). Multilocus enzyme electrophoretic typing (ET) suggested a clonal origin for both SEB-(55% of ET-5) and TSST-1 (76% of ET-19)-producing isolates. Thus, SEB may be an important cause in TSS where TSST-1 is not elaborated, especially in nonmenstrual TSS isolates.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1527429     DOI: 10.1093/infdis/166.4.911

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Diversity of toxic shock syndrome toxin 1-positive Staphylococcus aureus isolates.

Authors:  John E Warner; Andrew B Onderdonk
Journal:  Appl Environ Microbiol       Date:  2004-11       Impact factor: 4.792

2.  Understanding toxic shock syndrome.

Authors:  Jason P Burnham; Marin H Kollef
Journal:  Intensive Care Med       Date:  2015-05-14       Impact factor: 17.440

3.  Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus.

Authors:  Melissa J Karau; Mulualem E Tilahun; Ashton Krogman; Barbara A Osborne; Richard A Goldsby; Chella S David; Jayawant N Mandrekar; Robin Patel; Govindarajan Rajagopalan
Journal:  Virulence       Date:  2016-12-07       Impact factor: 5.882

4.  Interaction of staphylococcal toxic shock syndrome toxin-1 and enterotoxin A on T cell proliferation and TNFα secretion in human blood mononuclear cells.

Authors:  M L De Boer; W W Kum; A W Chow
Journal:  Can J Infect Dis       Date:  1999-11

5.  Frequency of toxic shock syndrome toxin- and enterotoxin-producing clinical isolates of Staphylococcus aureus.

Authors:  N Lehn; E Schaller; H Wagner; M Krönke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-01       Impact factor: 3.267

6.  Clonal study of enterotoxin-B producing strains of Staphylococcus aureus.

Authors:  F Renaud; N Bornstein; H Meugnier; F Forey; M Bes; J Fleurette
Journal:  Epidemiol Infect       Date:  1994-06       Impact factor: 2.451

7.  Involvement of enterotoxins G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever.

Authors:  S Jarraud; G Cozon; F Vandenesch; M Bes; J Etienne; G Lina
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

8.  Unexpected heterogeneity of multifunctional T cells in response to superantigen stimulation in humans.

Authors:  Monica A McArthur; Marcelo B Sztein
Journal:  Clin Immunol       Date:  2012-12-20       Impact factor: 3.969

9.  Staphylococcal Enterotoxin B-specific monoclonal antibody 20B1 successfully treats diverse Staphylococcus aureus infections.

Authors:  Avanish K Varshney; Xiaobo Wang; Matthew D Scharff; Jennifer MacIntyre; Richard S Zollner; Oleg V Kovalenko; Luis R Martinez; Fergus R Byrne; Bettina C Fries
Journal:  J Infect Dis       Date:  2013-08-06       Impact factor: 5.226

10.  IL-2 regulates SEB induced toxic shock syndrome in BALB/c mice.

Authors:  Aslam Ali Khan; Shilpee Priya; Bhaskar Saha
Journal:  PLoS One       Date:  2009-12-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.